Canis ISSN: 2398-2942

DOCP (US)

Synonym(s): Percorten-V; Desoxycortone pivalate

Contributor(s): Vetstream Ltd

Introduction

Name

  • DOCP

Class of drug

Description

Chemical name

  • 21 (2,2-dimethyl-1-oxopropoxy)-pregn-4-ene-3,20-dione

Molecular formula

  • C26 H38 O4

Molecular weight

  • 414.58

Physical properties

  • White odorless microcrystals.
  • Stable in air.
  • Soluble in methanol, ether and vegetable oils.

Storage requirements

  • Store at room temperature, preferably 15 - 30 degrees C (59 - 86 degrees F).
  • Protect from light.
  • Protect from freezing.

Uses

This article is available in full to registered subscribers

Sign up now to purchase a 30 day trial, or Login

Indications

  • Adrenocortical insufficiency (Addison's disease) Hypoadrenocorticism.
    It is essential to accurately diagnose primary canine adrenocortical insufficiency before administration.

Administration

This article is available in full to registered subscribers

Sign up now to purchase a 30 day trial, or Login

Precautions

This article is available in full to registered subscribers

Sign up now to purchase a 30 day trial, or Login

Adverse Reactions

This article is available in full to registered subscribers

Sign up now to purchase a 30 day trial, or Login

Further Reading

Publications

Refereed papers

  • Recent references from PubMed and VetMedResource.
  • MacCabe M D, Feldman E C, Lynn R C et al (1995) Subcutaneous Administration of Desoxycorticosterone Pivalate for the Treatment of Canine Hypoadrenocorticism. JAAHA 31 (2), 151-155 PubMed.
  • Lynn R C, Feldman E C, Nelson R W (1993) Efficacy of Microcrystalline Desoxycorticosterone Pivalate for Treatment of Hypoadrenocorticism in Dogs. DOCP Clinical Study Group. JAVMA 202 (3), 392-396 PubMed.
  • Lynn R C & Feldman E C (1991) Treatment of Canine Hypoadrenocorticism with Microcrystalline Desoxycorticosterone Pivalate. Br Vet J 147 (5), 478-483 PubMed.

Other sources of information


ADDED